Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Learn what's the best investment strategy to help you maximize your returns and achieve your financial goals.
22,631 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Ring CEO Jamie Siminoff says more home cameras could help investigators, a stance that elevates the debate over secur...
Bumble delivered a beat on Q4 2025 revenue as it unveiled Bee, an AI dating concierge. The move coincided with a dram...
Alibaba.com's leader previews a future where a single founder can run a global B2B business with AI handling the heav...
Bitcoin battles above the $80,000 mark as macro signals and industry moves shape the week. Traders debate strategy wh...
New market data shows most active managers fail to beat the S&P 500 over extended periods. This story explains the fo...
As Ethereum’s core stewardship rethinks its mission, Vitalik Buterin advocates a leaner, more opinionated foundation....
SpaceX is stepping into a new AI infrastructure role, powering Anthropic’s Claude as a neo cloud. The move reshapes t...
As IPO chatter heats up in 2026, SpaceX faces a pivotal moment. The CFO’s quiet leadership could define the deal, unl...
As crypto cycles unfold, investors ask which asset is best placed for the next bull. This guide breaks down Bitcoin v...
Applied Digital signals a slower AI data-center buildout through 2027 amid labor constraints, with hyperscalers pushi...
Ripple's chief executive describes a near-collapse moment in the 2020 SEC case and how the company fought on, reshapi...